48 Publications (Page 1 of 2)
2020
Clinical Assessment of 5-Fluorouracil/Leucovorin, Nab-Paclitaxel, and Irinotecan (FOLFIRABRAX) in Untreated Patients with Gastrointestinal Cancer Using UGT1A1 Genotype-Guided DosingJoshi, Smita⋅Joshi, Smita S⋅Joshi, Smita⋅Joshi, Smita S⋅Catenacci, Daniel V T⋅Catenacci, Daniel V T⋅Catenacci, Daniel V T⋅Catenacci, Daniel V T⋅Karrison, Theodore G⋅Karrison, Theodore G⋅Karrison, Theodore G⋅Karrison, Theodore G⋅Peterson, Jaclyn D⋅Peterson, Jaclyn D⋅Peterson, Jaclyn D⋅Peterson, Jaclyn D⋅Zalupski, Mark M⋅Zalupski, Mark M⋅Zalupski, Mark M⋅Zalupski, Mark M⋅Sehdev, Amikar⋅Sehdev, Amikar⋅Sehdev, Amikar⋅Sehdev, Amikar⋅Wade, James⋅Wade, James⋅Wade, James⋅Wade, James⋅Sadiq, Ahad⋅Sadiq, Ahad⋅Sadiq, Ahad⋅Sadiq, Ahad⋅Picozzi, Vincent J⋅Picozzi, Vincent J⋅Picozzi, Vincent J⋅Picozzi, Vincent J⋅Amico, Andrea⋅Amico, Andrea⋅Amico, Andrea⋅Amico, Andrea⋅Marsh, Robert⋅Marsh, Robert⋅Marsh, Robert⋅Marsh, Robert⋅Kozloff, Mark F⋅Kozloff, Mark F⋅Kozloff, Mark F⋅Kozloff, Mark F⋅Polite, Blase⋅Polite, Blase⋅Polite, Blase N⋅Polite, Blase N⋅Kindler, Hedy L⋅Kindler, Hedy⋅Kindler, Hedy⋅Kindler, Hedy L⋅Sharma, Manish R⋅Sharma, Manish R⋅Sharma, Manish R and Sharma, Manish RClinical cancer research : an official journal of the American Association for Cancer Research, vol. 26, (no. 1), pp. 24, 2020-Jan-01.
| Journal Article
Phase II study of fluorouracil (FU), leucovorin (LV), and nanoliposomal irinotecan (nal-IRI) in previously treated advanced biliary tract cancer (NAPOLI-2)Weinberg, Benjamin Adam⋅Wang, Hongkun⋅Pedersen, Katrina⋅Sehdev, Amikar⋅Sung, Max W and Hwang, Jimmy JJournal of Clinical Oncology, vol. 38, (no. 4_suppl), pp. TPS593, 2020-02-01.
| Journal Article
2019
Neoadjuvant therapy duration and outcome of patients with resectable and borderline resectable pancreatic ductal adenocarcinoma (PDAC)Shahda, Safi⋅Shahda, Safi⋅Shahda, Safi⋅Shahda, Safi⋅Shahda, Safi⋅Shahda, Safi⋅Shahda, Safi⋅Shahda, Safi⋅Perkins, Susan⋅Perkins, Susan⋅Perkins, Susan⋅Perkins, Susan⋅Perkins, Susan⋅Perkins, Susan⋅Perkins, Susan⋅Perkins, Susan⋅Cramer, Harvey M⋅Cramer, Harvey M⋅Cramer, Harvey M⋅Cramer, Harvey M⋅Cramer, Harvey M⋅Cramer, Harvey M⋅Cramer, Harvey M⋅Cramer, Harvey M⋅House, Michael Garrett⋅House, Michael Garrett⋅House, Michael Garrett⋅House, Michael Garrett⋅House, Michael Garrett⋅House, Michael Garrett⋅House, Michael Garrett⋅House, Michael Garrett⋅Nakeeb, Attila⋅Nakeeb, Attila⋅Nakeeb, Attila⋅Nakeeb, Attila⋅Nakeeb, Attila⋅Nakeeb, Attila⋅Nakeeb, Attila⋅Nakeeb, Attila⋅Zyromski, Nicholas J⋅Zyromski, Nicholas J⋅Zyromski, Nicholas J⋅Zyromski, Nicholas J⋅Zyromski, Nicholas J⋅Zyromski, Nicholas J⋅Zyromski, Nicholas J⋅Zyromski, Nicholas J⋅Ceppa, Eugene P⋅Ceppa, Eugene P⋅Ceppa, Eugene P⋅Ceppa, Eugene P⋅Ceppa, Eugene P⋅Ceppa, Eugene P⋅Ceppa, Eugene P⋅Ceppa, Eugene P⋅Sehdev, Amikar⋅Sehdev, Amikar⋅Sehdev, Amikar⋅Sehdev, Amikar⋅Sehdev, Amikar⋅Sehdev, Amikar⋅Sehdev, Amikar⋅Sehdev, Amikar⋅Akisik, Fatih⋅Akisik, Fatih⋅Akisik, Fatih⋅Akisik, Fatih⋅Akisik, Fatih⋅Akisik, Fatih⋅Akisik, Fatih⋅Akisik, Fatih⋅Lin, Jingmei⋅Lin, Jingmei⋅Lin, Jingmei⋅Lin, Jingmei⋅Lin, Jingmei⋅Lin, Jingmei⋅Lin, Jingmei⋅Lin, Jingmei⋅Schmidt, Christian⋅Schmidt, Christian⋅Schmidt, Christian⋅Schmidt, Christian⋅Schmidt, Christian⋅Schmidt, Christian⋅Schmidt, Christian⋅Schmidt, Christian⋅Ellsworth, Susannah G⋅Ellsworth, Susannah G⋅Ellsworth, Susannah G⋅Ellsworth, Susannah G⋅Ellsworth, Susannah G⋅Ellsworth, Susannah G⋅Ellsworth, Susannah G⋅Ellsworth, Susannah G⋅O'Neil, Nina⋅O'Neil, Nina⋅O'Neil, Nina⋅O'Neil, Nina⋅O'Neil, Nina⋅O'Neil, Nina⋅O'Neil, Nina⋅O'Neil, Nina⋅Link, Kristen⋅Link, Kristen⋅Link, Kristen⋅Link, Kristen⋅Link, Kristen⋅Link, Kristen⋅Link, Kristen⋅Link, Kristen⋅O'Neil, Bert⋅O'Neil, Bert⋅O'Neil, Bert⋅O'Neil, Bert⋅O'Neil, Bert⋅O'Neil, Bert⋅O'Neil, Bert and O'Neil, BertJournal of Clinical Oncology, vol. 37, (no. 4_suppl), pp. 436, 2019-02-01.
| Journal Article
Overall survival of patients with recurrent pancreatic cancer treated with systemic therapy: a retrospective studyGbolahan, Olumide B⋅Tong, Yan and Sehdev, AmikarBMC Cancer, vol. 19, 2019.
| Journal Article
Phase 1 study of EUS-guided photodynamic therapy for locally advanced pancreatic cancerDeWitt, John M⋅De Witt, John M⋅Sandrasegaran, Kumar⋅Sandrasegaran, Kumar⋅O'Neil, Bert⋅O'Neil, Bert⋅House, Michael G⋅House, Michael G⋅Zyromski, Nicholas J⋅Zyromski, Nicholas J⋅Sehdev, Amikar⋅Sehdev, Amikar⋅Perkins, Susan M⋅Perkins, Susan M⋅Flynn, Janet⋅Flynn, Janet⋅McCranor, Lynne⋅McCranor, Lynne⋅Shahda, Safi and Shahda, SafiGastrointestinal Endoscopy, vol. 89, (no. 2), pp. 398, February 2019.
| Journal Article
2018
A pharmacodynamic study of sirolimus and metformin in patients with advanced solid tumorsSehdev, Amikar⋅Sehdev, Amikar⋅Sehdev, Amikar⋅Karrison, Theodore⋅Karrison, Theodore⋅Karrison, Theodore⋅Zha, Yuanyuan⋅Zha, Yuanyuan⋅Zha, Yuanyuan⋅Janisch, Linda⋅Janisch, Linda⋅Janisch, Linda⋅Turcich, Michelle⋅Turcich, Michelle⋅Turcich, Michelle⋅Cohen, Ezra E W⋅Cohen, Ezra⋅Cohen, Ezra E⋅Maitland, Michael⋅Maitland, Michael⋅Maitland, Michael⋅Polite, Blase N⋅Polite, Blase⋅Polite, Blase N⋅Gajewski, Thomas⋅Gajewski, Thomas F⋅Gajewski, Thomas F⋅Salgia, Ravi⋅Salgia, Ravi⋅Salgia, Ravi⋅Pinto, Navin⋅Pinto, Navin⋅Pinto, Navin⋅Bissonnette, Marc B⋅Bissonnette, Marc⋅Bissonnette, Marc B⋅Fleming, Gini⋅Fleming, Gini F⋅Fleming, Gini F⋅Ratain, Mark J⋅Ratain, Mark⋅Ratain, Mark J⋅Sharma, Manish R⋅Sharma, Manish and Sharma, Manish RCancer Chemotherapy and Pharmacology, vol. 82, (no. 2), pp. 317, 20180800.
| Journal Article
A phase II trial of cabozantinib and erlotinib for patients with EGFR and c-MET co-expressing metastatic pancreatic adenocarcinomaGbolahan, Olumide B⋅Gbolahan, Olumide B⋅Gbolahan, Olumide B⋅Gbolahan, Olumide B⋅Sehdev, Amikar⋅Sehdev, Amikar⋅Sehdev, Amikar⋅Sehdev, Amikar⋅Shahda, Safi⋅Shahda, Safi⋅Shahda, Safi⋅Shahda, Safi⋅Perkins, Susan⋅Perkins, Susan⋅Perkins, Susan⋅Perkins, Susan⋅Korc, Murray⋅Korc, Murray⋅Korc, Murray⋅Korc, Murray⋅Loehrer, Patrick J⋅Loehrer, Patrick J⋅Loehrer, Patrick J⋅Loehrer, Patrick J⋅O'Neil, Bert H⋅O'Neil, Bert H⋅O'Neil, Bert H and O'Neil, Bert HJournal of Clinical Oncology, vol. 36, (no. 15_suppl), pp. TPS4157, 2018-05-20.
| Journal Article
Association of RAS mutations with race in metastatic colorectal cancer: CALGB/SWOG 80405 (ALLIANCE)Sehdev, Amikar⋅Sehdev, Amikar⋅Sehdev, Amikar⋅Niedzwiecki, Donna⋅Niedzwiecki, Donna⋅Niedzwiecki, Donna⋅Venook, Alan P.⋅Venook, Alan P⋅Venook, Alan P⋅Lenz, Heinz-Josef⋅Lenz, Heinz-Josef⋅Lenz, Heinz-Josef⋅Innocenti, Federico⋅Innocenti, Federico⋅Innocenti, Federico⋅Mahoney, Michelle R⋅Mahoney, Michelle R.⋅Mahoney, Michelle R⋅Shaw, James Edward⋅Shaw, James Edward⋅Shaw, James Edward⋅Polite, Blase N.⋅Polite, Blase N⋅Polite, Blase N⋅Hochster, Howard S.⋅Hochster, Howard S⋅Hochster, Howard S⋅Atkins, James Norman⋅Atkins, James Norman⋅Atkins, James Norman⋅Goldberg, Richard⋅Goldberg, Richard⋅Goldberg, Richard⋅Mayer, Robert J.⋅Mayer, Robert J⋅Mayer, Robert J⋅Schilsky, Richard L⋅Schilsky, Richard L⋅Schilsky, Richard L.⋅Bertagnolli, Monica M⋅Bertagnolli, Monica M⋅Bertagnolli, Monica M.⋅Blanke, Charles David⋅Blanke, Charles David⋅Blanke, Charles David⋅O'Neil, Bert H.⋅O'Neil, Bert H and O'Neil, Bert HJournal of Clinical Oncology, vol. 36, (no. 4_suppl), pp. 638, 2018-02-01.
| Journal Article
Germline and Somatic DNA Damage Repair Gene Mutations and Overall Survival in Metastatic Pancreatic Adenocarcinoma Patients Treated with FOLFIRINOXSehdev, Amikar⋅Sehdev, Amikar⋅Gbolahan, Olumide⋅Gbolahan, Olumide⋅Hancock, Brad A⋅Hancock, Brad A⋅Stanley, Melissa⋅Stanley, Melissa⋅Shahda, Safi⋅Shahda, Safi⋅Wan, Jun⋅Wan, Jun⋅Wu, Howard H⋅Wu, Howard H⋅Radovich, Milan⋅Radovich, Milan⋅O'Neil, Bert H and O'Neil, Bert HClinical cancer research : an official journal of the American Association for Cancer Research, vol. 24, (no. 24), pp. 6211, 2018-12-15.
| Journal Article
Integrating therapies for surgical adult soft tissue sarcoma patientsMilgrom, Daniel P⋅Milgrom, Daniel P⋅Sehdev, Amikar⋅Sehdev, Amikar⋅Kays, Joshua K⋅Kays, Joshua K⋅Koniaris, Leonidas G and Koniaris, Leonidas GTranslational gastroenterology and hepatology, vol. 3, pp. 88, 2018-00-00.
| Journal Article
Prognostic role of BRAF mutation in malignant cutaneous melanomaSehdev, Amikar⋅Sehdev, Amikar⋅Sehdev, Amikar⋅Sehdev, Amikar⋅Sehdev, Amikar⋅Hayden, Ross⋅Hayden, Ross⋅Hayden, Ross⋅Hayden, Ross⋅Hayden, Ross⋅Kuhar, Mathew Joseph⋅Kuhar, Mathew Joseph⋅Kuhar, Mathew Joseph⋅Kuhar, Mathew Joseph⋅Kuhar, Mathew Joseph⋅Cheng, Liang⋅Cheng, Liang⋅Cheng, Liang⋅Cheng, Liang⋅Cheng, Liang⋅Warren, Simon John⋅Warren, Simon John⋅Warren, Simon John⋅Warren, Simon John⋅Warren, Simon John⋅Mark, Lawrence Aaron⋅Mark, Lawrence Aaron⋅Mark, Lawrence Aaron⋅Mark, Lawrence Aaron⋅Mark, Lawrence Aaron⋅Wooden, William Arthur⋅Wooden, William Arthur⋅Wooden, William Arthur⋅Wooden, William Arthur⋅Wooden, William Arthur⋅Schwartzentruber, Douglas Jay⋅Schwartzentruber, Douglas Jay⋅Schwartzentruber, Douglas Jay⋅Schwartzentruber, Douglas Jay⋅Schwartzentruber, Douglas Jay⋅Logan, Theodore F⋅Logan, Theodore F⋅Logan, Theodore F⋅Logan, Theodore F and Logan, Theodore FJournal of Clinical Oncology, vol. 36, (no. 15_suppl), pp. e21599, 2018-05-20.
| Journal Article
Prospective trial of preoperative FOLFIRINOX in patients with resectable pancreatic ductal adenocarcinoma (PDAC): Report of early endpointsShahda, Safi⋅Shahda, Safi⋅Shahda, Safi⋅Shahda, Safi⋅Shahda, Safi⋅Shahda, Safi⋅Shahda, Safi⋅Shahda, Safi⋅Shahda, Safi⋅House, Michael Garrett⋅House, Michael Garrett⋅House, Michael Garrett⋅House, Michael Garrett⋅House, Michael Garrett⋅House, Michael Garrett⋅House, Michael Garrett⋅House, Michael Garrett⋅House, Michael Garrett⋅Zyromski, Nicholas J⋅Zyromski, Nicholas J⋅Zyromski, Nicholas J⋅Zyromski, Nicholas J⋅Zyromski, Nicholas J⋅Zyromski, Nicholas J⋅Zyromski, Nicholas J⋅Zyromski, Nicholas J⋅Zyromski, Nicholas J⋅Sehdev, Amikar⋅Sehdev, Amikar⋅Sehdev, Amikar⋅Sehdev, Amikar⋅Sehdev, Amikar⋅Sehdev, Amikar⋅Sehdev, Amikar⋅Sehdev, Amikar⋅Sehdev, Amikar⋅Cramer, Harvey M⋅Cramer, Harvey M⋅Cramer, Harvey M⋅Cramer, Harvey M⋅Cramer, Harvey M⋅Cramer, Harvey M⋅Cramer, Harvey M⋅Cramer, Harvey M⋅Cramer, Harvey M⋅Flynn, Janet⋅Flynn, Janet⋅Flynn, Janet⋅Flynn, Janet⋅Flynn, Janet⋅Flynn, Janet⋅Flynn, Janet⋅Flynn, Janet⋅Flynn, Janet⋅Akisik, Fatih⋅Akisik, Fatih⋅Akisik, Fatih⋅Akisik, Fatih⋅Akisik, Fatih⋅Akisik, Fatih⋅Akisik, Fatih⋅Akisik, Fatih⋅Akisik, Fatih⋅Ceppa, Eugene P⋅Ceppa, Eugene P⋅Ceppa, Eugene P⋅Ceppa, Eugene P⋅Ceppa, Eugene P⋅Ceppa, Eugene P⋅Ceppa, Eugene P⋅Ceppa, Eugene P⋅Ceppa, Eugene P⋅Schmidt, C. Max⋅Schmidt, C. Max⋅Schmidt, C. Max⋅Schmidt, C. Max⋅Schmidt, C. Max⋅Schmidt, C. Max⋅Schmidt, C. Max⋅Schmidt, C. Max⋅Schmidt, C. Max⋅Nakeeb, Attila⋅Nakeeb, Attila⋅Nakeeb, Attila⋅Nakeeb, Attila⋅Nakeeb, Attila⋅Nakeeb, Attila⋅Nakeeb, Attila⋅Nakeeb, Attila⋅Nakeeb, Attila⋅Lin, Jingmei⋅Lin, Jingmei⋅Lin, Jingmei⋅Lin, Jingmei⋅Lin, Jingmei⋅Lin, Jingmei⋅Lin, Jingmei⋅Lin, Jingmei⋅Lin, Jingmei⋅Perkins, Susan M⋅Perkins, Susan M⋅Perkins, Susan M⋅Perkins, Susan M⋅Perkins, Susan M⋅Perkins, Susan M⋅Perkins, Susan M⋅Perkins, Susan M⋅Perkins, Susan M⋅Burney, Heather⋅Burney, Heather⋅Burney, Heather⋅Burney, Heather⋅Burney, Heather⋅Burney, Heather⋅Burney, Heather⋅Burney, Heather⋅Burney, Heather⋅O'Neil, Bert H⋅O'Neil, Bert H⋅O'Neil, Bert H⋅O'Neil, Bert H⋅O'Neil, Bert H⋅O'Neil, Bert H⋅O'Neil, Bert H⋅O'Neil, Bert H and O'Neil, Bert HJournal of Clinical Oncology, vol. 36, (no. 15_suppl), pp. 4118, 2018-05-20.
| Journal Article
Safety and tolerability of 5-FU, irinotecan (IRI), and nab-paclitaxel (FOLFIRABRAX) with genotype-guided dosing of IRI in previously untreated patients with advanced gastrointestinal (GI) malignanciesJoshi, Smita Suhas⋅Karrison, Theodore G⋅Catenacci, Daniel V.T⋅Peterson, Jaclyn D⋅Zalupski, Mark⋅Phillips, Brooke Elizabeth⋅Sadiq, Ahad Ali⋅Sehdev, Amikar⋅Wade, James Lloyd⋅Picozzi, Vincent J⋅Amico, Andrea Louise⋅Kozloff, Mark⋅Polite, Blase N⋅Kindler, Hedy L and Sharma, ManishJournal of Clinical Oncology, vol. 36, (no. 4_suppl), pp. 423, 2018-02-01.
| Journal Article
Safety and tolerability of FOLFIRABRAX [5-Fluourouracil (5-FU), irinotecan (IRI), and nab-paclitaxel (NP)] with genotype-guided dosing of IRI in previously untreated advanced gastrointestinal (GI) cancer patients (pts): A multicenter trial of the University of Chicago Personalized Cancer Care ConsortiumJoshi, Smita Suhas⋅Karrison, Theodore⋅Catenacci, Daniel V.T⋅Peterson, Jaclyn D⋅Zalupski, Mark⋅Phillips, Brooke Elizabeth⋅Sadiq, Ahad Ali⋅Sehdev, Amikar⋅Wade, James Lloyd⋅Picozzi, Vincent J⋅Amico, Andrea Louise⋅Marsh, Robert de Wilton⋅Kozloff, Mark⋅Polite, Blase N⋅Kindler, Hedy L and Sharma, ManishJournal of Clinical Oncology, vol. 36, (no. 15_suppl), pp. e16241, 2018-05-20.
| Journal Article
Su1367 PHASE I STUDY OF EUS-GUIDED PHOTODYNAMIC THERAPY FOR LOCALLY ADVANCED PANCREATIC CANCERDeWitt, John M⋅DeWitt, John M⋅De Witt, John M⋅Sandrasegaran, Kumar⋅Sandrasegaran, Kumar⋅Sandrasegaran, Kumar⋅Perkins, Susan⋅Perkins, Susan⋅Perkins, Susan⋅O'Neil, Bert⋅O'Neil, Bert⋅O'Neil, Bert⋅House, Michael G⋅House, Michael G⋅House, Michael G⋅Zyromski, Nicholas J⋅Zyromski, Nicholas J⋅Zyromski, Nicholas J⋅Sehdev, Amikar⋅Sehdev, Amikar⋅Sehdev, Amikar⋅Shahda, Safi⋅Shahda, Safi and Shahda, SafiGastrointestinal Endoscopy, vol. 87, (no. 6), pp. AB324, June 2018.
| Journal Article
The impact of research presented at annual gastrointestinal cancers symposiumSehdev, Amikar⋅Sehdev, Amikar⋅Sehdev, Amikar⋅Dadi, Neelakanta⋅Dadi, Neelakanta⋅Dadi, Neelakanta⋅Haggstrom, David Andrew⋅Haggstrom, David Andrew⋅Haggstrom, David Andrew⋅Koniaris, Leonidas George⋅Koniaris, Leonidas George⋅Koniaris, Leonidas George⋅O'Neil, Bert H⋅O'Neil, Bert H and O'Neil, Bert HJournal of Clinical Oncology, vol. 36, (no. 4_suppl), pp. 757, 2018-02-01.
| Journal Article
2017
A pharmacodynamic study of sirolimus and metformin in patients with advanced solid tumorsSehdev, Amikar⋅Zha, Yuanyuan⋅Karrison, Theodore G⋅Janisch, Linda A⋅Cohen, Ezra E.W⋅Maitland, Michael L⋅Polite, Blase N⋅Turcich, Michelle⋅Fleming, Gini F⋅Salgia, Ravi⋅Pinto, Navin R⋅Gajewski, Thomas⋅Bissonnette, Marc⋅Ratain, Mark J and Sharma, ManishJournal of Clinical Oncology, vol. 35, (no. 15_suppl), pp. TPS11628, 2017-05-20.
| Journal Article
A phase Ib/II study of cancer stemness inhibitor napabucasin (BBI-608) in combination with gemcitabine (gem) and nab-paclitaxel (nabPTX) in metastatic pancreatic adenocarcinoma (mPDAC) patients (pts)Bekaii-Saab, Tanios S⋅Bekaii-Saab, Tanios S⋅Starodub, Alexander⋅Starodub, Alexander⋅El-Rayes, Bassel F⋅El-Rayes, Bassel F⋅O'Neil, Bert H⋅O'Neil, Bert H⋅Shahda, Safi⋅Shahda, Safi⋅Ciombor, Kristen Keon⋅Ciombor, Kristen Keon⋅Noonan, Anne M⋅Noonan, Anne M⋅Hanna, Wahid Tewfik⋅Hanna, Wahid Tewfik⋅Sehdev, Amikar⋅Sehdev, Amikar⋅Shaib, Walid Labib⋅Shaib, Walid Labib⋅Mikhail, Sameh⋅Mikhail, Sameh⋅Neki, Anterpreet S⋅Neki, Anterpreet S⋅Oh, Cindy⋅Oh, Cindy⋅Li, Youzhi⋅Li, Youzhi⋅Li, Wei⋅Li, Wei⋅Borodyansky, Laura⋅Borodyansky, Laura⋅Li, Chiang and Li, ChiangJournal of Clinical Oncology, vol. 35, (no. 15_suppl), pp. 4106, 2017-05-20.
| Journal Article
A phase II study of pembrolizumab in combination with mFOLFOX6 for patients with advanced colorectal cancerShahda, Safi⋅Shahda, Safi⋅Shahda, Safi⋅Shahda, Safi⋅Noonan, Anne M⋅Noonan, Anne M⋅Noonan, Anne M⋅Noonan, Anne M⋅Bekaii-Saab, Tanios S⋅Bekaii-Saab, Tanios S⋅Bekaii-Saab, Tanios S⋅Bekaii-Saab, Tanios S⋅O'Neil, Bert H⋅O'Neil, Bert H⋅O'Neil, Bert H⋅O'Neil, Bert H⋅Sehdev, Amikar⋅Sehdev, Amikar⋅Sehdev, Amikar⋅Sehdev, Amikar⋅Shaib, Walid Labib⋅Shaib, Walid Labib⋅Shaib, Walid Labib⋅Shaib, Walid Labib⋅Helft, Paul R⋅Helft, Paul R⋅Helft, Paul R⋅Helft, Paul R⋅Loehrer, Patrick J⋅Loehrer, Patrick J⋅Loehrer, Patrick J⋅Loehrer, Patrick J⋅Tong, Yan⋅Tong, Yan⋅Tong, Yan⋅Tong, Yan⋅Liu, Ziyue⋅Liu, Ziyue⋅Liu, Ziyue⋅Liu, Ziyue⋅El-Rayes, Bassel F⋅El-Rayes, Bassel F⋅El-Rayes, Bassel F and El-Rayes, Bassel FJournal of Clinical Oncology, vol. 35, (no. 15_suppl), pp. 3541, 2017-05-20.
| Journal Article
Demographic, clinical, and outcomes characteristics associated with screening colonoscopy in colorectal cancer patientsArmstrong, Samantha Ann⋅Armstrong, Samantha Ann⋅Shahda, Safi⋅Shahda, Safi⋅Sehdev, Amikar and Sehdev, AmikarJournal of Clinical Oncology, vol. 35, (no. 4_suppl), pp. 554, 2017-02-01.
| Journal Article
Excellent response to Anti-PD-1 therapy in a patient with hepatocellular carcinoma: case report and review of literatureMamdani, Hirva⋅Wu, Howard⋅O'Neil, Bert H and Sehdev, AmikarDiscovery medicine, vol. 23, (no. 128), pp. 331, 2017-05-00.
| Journal Article
Impact of Nab–Paclitaxel-based Second-line Chemotherapy in Metastatic Pancreatic CancerDadi, Neelakanta⋅Stanley, Melissa⋅Shahda, Safi⋅O'Neil, Bert H and Sehdev, AmikarAnticancer research, vol. 37, (no. 10), pp. 5533, 2017-10-00.
| Journal Article
Impact of nab-paclitaxel-based second-line chemotherapy on the outcomes of pancreatic cancerDadi, Neelakanta⋅Dadi, Neelakanta⋅Shahda, Safi⋅Shahda, Safi⋅O'Neil, Bert H⋅O'Neil, Bert H⋅Sehdev, Amikar and Sehdev, AmikarJournal of Clinical Oncology, vol. 35, (no. 4_suppl), pp. 483, 2017-02-01.
| Journal Article
Patterns of computed tomography surveillance in survivors of colorectal cancer at Veterans Health Administration facilitiesSehdev, Amikar⋅Sehdev, Amikar⋅Sherer, Eric A⋅Sherer, Eric A⋅Hui, Siu L⋅Hui, Siu L⋅Wu, Jingwei⋅Wu, Jingwei⋅Haggstrom, David A and Haggstrom, David ACancer, vol. 123, (no. 12), pp. 2338-2351, Jun 2017.
| Journal Article
Survival after recurrence following curative intent resection of pancreatic adenocarcinomaEllsworth, Susannah G⋅Ellsworth, Susannah G⋅Ellsworth, Susannah G⋅Ellsworth, Susannah G⋅Stanley, Melissa⋅Stanley, Melissa⋅Stanley, Melissa⋅Stanley, Melissa⋅House, Michael Garrett⋅House, Michael Garrett⋅House, Michael Garrett⋅House, Michael Garrett⋅Nakeeb, Attila⋅Nakeeb, Attila⋅Nakeeb, Attila⋅Nakeeb, Attila⋅Shahda, Safi⋅Shahda, Safi⋅Shahda, Safi⋅Shahda, Safi⋅Schmidt, Christian⋅Schmidt, Christian⋅Schmidt, Christian⋅Schmidt, Christian⋅Zyromski, Nicholas J⋅Zyromski, Nicholas J⋅Zyromski, Nicholas J⋅Zyromski, Nicholas J⋅O'Neil, Bert H⋅O'Neil, Bert H⋅O'Neil, Bert H⋅O'Neil, Bert H⋅Sehdev, Amikar⋅Sehdev, Amikar⋅Sehdev, Amikar and Sehdev, AmikarJournal of Clinical Oncology, vol. 35, (no. 15_suppl), pp. e15760, 2017-05-20.
| Journal Article